v3.25.3
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2024
EUR (€)
Nov. 30, 2020
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Aug. 31, 2024
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
May 31, 2022
USD ($)
Nov. 30, 2021
USD ($)
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Research and development       $ 2,281,174 $ 1,079,620 $ 6,705,898 $ 2,552,421          
Research and consulting agreement | Therapeutics Inc.                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Research and development       522,000 $ 275,000 1,281,000 $ 926,000          
Research and consulting agreement | Scleroderma                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Total amount of agreement                     $ 610,000  
Research and consulting agreement | The School of Pharmacy at UCC                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Maximum funding amount $ 665,000 € 567,000                    
Commitment period 2 years 6 months 2 years 6 months                    
Accrued research and development expense       $ 48,000   $ 168,000            
Consulting agreements | Netherton Syndrome                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Total amount of agreement                       $ 250,000
Consulting agreements | Therapeutics Inc.                        
RESEARCH, CONSULTING AGREEMENTS AND COMMITMENTS                        
Initial term     3 years                  
Written termination notice period     90 days                  
Total amount of agreement               $ 3,600,000 $ 830,000 $ 4,400,000